BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31336472)

  • 1. Serum leptin in diabetic nephropathy male patients from Gaza Strip.
    Yassin MM; AbuMustafa AM; Yassin MM
    Diabetes Metab Syndr; 2019; 13(2):1245-1250. PubMed ID: 31336472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function.
    Chen CC; Susanto H; Chuang WH; Liu TY; Wang CH
    Cardiovasc Diabetol; 2016 Jan; 15():3. PubMed ID: 26739836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased leptin concentrations and lack of gender difference in Type 2 diabetic patients with nephropathy.
    Chan WB; Ma RC; Chan NN; Ng MC; Lee ZS; Lai CW; Tong PC; So WY; Chan JC
    Diabetes Res Clin Pract; 2004 May; 64(2):93-8. PubMed ID: 15063601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microalbuminuria, Other Markers of Nephropathy and Biochemical Derangementsin Type 2 Diabetes Mellitus: Relationships and Determinants.
    Idowu AA; Ajose AO; Adedeji AT; Adegoke AO; Jimoh KA
    Ghana Med J; 2017 Jun; 51(2):56-63. PubMed ID: 28955101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta2-microglobulin and cystatin C in type 2 diabetes: assessment of diabetic nephropathy.
    Aksun SA; Ozmen D; Ozmen B; Parildar Z; Mutaf I; Turgan N; Habif S; Kumanlioğluc K; Bayindir O
    Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):195-200. PubMed ID: 15127324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triglyceride-glucose index: A surrogate marker of homeostasis model assessment of insulin resistance to predict diabetic nephropathy.
    Khan S; Qayyum S; Khan MNA
    J Pak Med Assoc; 2024 May; 74(5):862-867. PubMed ID: 38783431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The comparison of cystatin C and creatinine as an accurate serum marker in the prediction of type 2 diabetic nephropathy.
    Lee BW; Ihm SH; Choi MG; Yoo HJ
    Diabetes Res Clin Pract; 2007 Dec; 78(3):428-34. PubMed ID: 17822797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum and Urinary Progranulin in Diabetic Kidney Disease.
    Nicoletto BB; Krolikowski TC; Crispim D; Canani LH
    PLoS One; 2016; 11(10):e0165177. PubMed ID: 27776152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated serum leptin concentrations in type 2 diabetic patients with microalbuminuria and macroalbuminuria.
    Fruehwald-Schultes B; Kern W; Beyer J; Forst T; Pfützner A; Peters A
    Metabolism; 1999 Oct; 48(10):1290-3. PubMed ID: 10535393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RISK FACTORS FOR DIABETIC NEPHROPATHY IN DIABETES MELLITUS TYPE 1.
    Mohammed MM; Alnajim EK; Hussein MAA; Hadi NR
    Wiad Lek; 2023; 76(1):145-154. PubMed ID: 36883503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum and urinary nitric oxide in Type 2 diabetes with or without microalbuminuria: relation to glomerular hyperfiltration.
    Apakkan Aksun S; Ozmen B; Ozmen D; Parildar Z; Senol B; Habif S; Mutaf I; Turgan N; Bayindir O
    J Diabetes Complications; 2003; 17(6):343-8. PubMed ID: 14583179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary heme oxygenase-1 as a potential biomarker for early diabetic nephropathy.
    Li Z; Xu Y; Liu X; Nie Y; Zhao Z
    Nephrology (Carlton); 2017 Jan; 22(1):58-64. PubMed ID: 26733347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum myeloid-related protein 8/14 is a potential predictor of diabetic kidney disease.
    Gu W; Cui J; Shi M; Zhang R; Tan D; Zhang X; Zhang H
    Discov Med; 2020; 30(160):97-105. PubMed ID: 33382965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and Biochemical Associations with Diabetic Retinopathy in Male Patients in the Gaza Strip.
    AbuMustafa AM
    Front Endocrinol (Lausanne); 2017; 8():302. PubMed ID: 29176961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of Angiopoietin-2 and vascular endothelial growth factor as markers of diabetic nephropathy onset in Egyptians diabetic patients with non-albuminuric state.
    Aly MH; Arafat MA; Hussein OA; Elsaid HH; Abdel-Hammed AR
    Diabetes Metab Syndr; 2019; 13(2):1623-1627. PubMed ID: 31336531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress markers in type 2 diabetes patients with diabetic nephropathy.
    Chou ST; Tseng ST
    Clin Exp Nephrol; 2017 Apr; 21(2):283-292. PubMed ID: 27233502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum vitamin D status in type 2 diabetic patients from Gaza Strip.
    Yassin MM; Masoud AED; Yasin MM
    Diabetes Metab Syndr; 2019; 13(3):1865-1870. PubMed ID: 31235107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum lipoprotein(a) levels and diabetic nephropathy among Japanese patients with type 2 diabetes mellitus.
    Senba H; Furukawa S; Sakai T; Niiya T; Miyake T; Yamamoto S; Ueda T; Torisu M; Minami H; Miyaoka H; Onji M; Tanaka K; Matsuura B; Tanigawa T; Hiasa Y; Miyake Y
    J Diabetes Complications; 2016 Jul; 30(5):923-7. PubMed ID: 26947887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Change and significance of urinary smad3 in type 2 diabetic nephropathy].
    Guo KF; Kou JX; Lu JX; Zhang L; Yu HY; Chen HB
    Zhonghua Yi Xue Za Zhi; 2013 Apr; 93(14):1067-71. PubMed ID: 23902838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atherogenic lipoprotein changes in diabetic nephropathy.
    Shoji T; Emoto M; Kawagishi T; Kimoto E; Yamada A; Tabata T; Ishimura E; Inaba M; Okuno Y; Nishizawa Y
    Atherosclerosis; 2001 Jun; 156(2):425-33. PubMed ID: 11395040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.